Association of metabolic syndrome with white blood cell subtype and red blood cells

Endocrine Journal

Volumn 53, Issue 1, 2006, Pages 133-139

  Kim, Jeong A ^a   Choi, Youn Seon ^a   Hong, Jeong Ik ^b   Kim, Su Hyun ^a   Jung, Hoe Hyun ^a   Kim, Seon Mee ^a  

^a Korea University College of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

Author keywords

Lymphocyte; Metabolic syndrome; Neutrophil; Red blood cell; White blood cell

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BASOPHIL; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; ERYTHROCYTE; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MONOCYTE; NEUTROPHIL; NEUTROPHIL COUNT; SEX DIFFERENCE;

ADULT; AUTOANALYSIS; BASOPHILS; EOSINOPHILS; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LYMPHOCYTES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MONOCYTES; NEUTROPHILS; SEX CHARACTERISTICS;

EID: 33644938769     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.133     Document Type: Article

References (40)

1. (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421.
2. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689.
3. Girman CJ, Rhodes T, Mercuri M, Pyorala K, Kjekshus J, Pedersen TR, Beere PA, Gotto AM, Clearfield M (2004) The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol 93: 136-141.
4. Kullo IJ, Cassidy AE, Peyser PA, Turner ST, Sheedy PF 2nd, Bielak LF (2004) Association between metabolic syndrome and subclinical coronary atherosclerosis in asymptomatic adults. Am J Cardiol 94: 1554-1558.
5. Lindsay RS, Howard BV (2004) Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep 4: 63-68.
6. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE (2004) Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 109: 714-721.
7. Muntner P, He J, Chen J, Fonseca V, Whelton PK (2004) Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 14: 686-695.
8. (2005) Important death cause in Korea; 2003 Korea National Statistical Office, Seoul.
9. (2004) Heart Disease and Stroke Statistics; 2004 update. American Heart Association.
10. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S; Study of Health Assessment and Risk in Ethinic Groups; Study of Health Assessment and Risk Evaluation in Adoriginal Peoples Investigators (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108: 420-425.
11. Fernandez-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42: 1367-1374.
12. Pickup JC, Crook MA (1998) Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248.
13. Freedman DS, Flanders WD, Barboriak JJ, Malarcher AM, Gates L (1996) Cigarette smoking and leukocyte subpopulations in men. Ann Epidemiol 6: 299-306.
14. Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 84: 553-558.
15. Shimakawa T, Bild DE (1993) Relationship between hemoglobin and cardiovascular risk factors in young adults. J Clin Epidemiol 46: 1257-1266.
16. (2000) The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. World Health Organization, pp. 1-55.
17. Nagasawa N, Tamakoshi K, Yatsuya H, Hori Y, Ishikawa M, Murata C, Zhang H, Wada K, Otsuka R, Mabuchi T, Kondo T, Toyoshima H (2004) Association of white blood cell count and clustered components of metabolic syndrome in Japanese men. Circ J 68: 892-897.
18. MH S, IG J (2004) Disorders of granulocytes and monocytes. In: Harrison's Principles of Internal Medicine, edn 16, 349-357.
19. Ble A, Palmieri E, Volpato S, Costantini F, Fellin R, Zuliani G (2001) White blood cell count is associated with some features of metabolic syndrome in a very old population. Nutr Metab Cardiovasc Dis 11: 221-226.
20. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, Renlund DG, Muhlestein JB (2005) Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45: 1638-1643.
21. Kawaguchi H, Mori T, Kawano T, Kono S, Sasaki J, Arakawa K (1996) Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 132: 9-12.
22. Sweetnam PM, Thomas HF, Yarnell JW, Baker IA, Elwood PC (1997) Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies. Am J Epidemiol 145: 416-421.
23. Prentice RL, Szatrowski TP, Fujikura T, Kato H, Mason MW, Hamilton HH (1982) Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 116: 496-509.
24. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, Meda P, Chizzolini C, Meier CA (2005) Production of chemokines by perivascular adipose tissue. A role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25: 2594-2599.
25. Smith MR, Kinmonth AL, Luben RN, Bingham S, Day NE, Wareham NJ, Welch A, Khaw KT (2003) Smoking status and differential white cell count in men and women in the EPIC-Norfolk population. Atherosclerosis 169: 331-337.
26. Sunyer J, Munoz A, Peng Y, Margolick J, Chmiel JS, Oishi J, Kingsley L, Samet JM (1996) Longitudinal relation between smoking and white blood cells. Am J Epidemiol 144: 734-741.
27. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308: 1583-1587.
28. Caulin-Glaser T, Watson CA, Pardi R, Bender JR (1996) Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98: 36-42.
29. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L, Paolisso G (2001) New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 44: 1232-1237.
30. Bersch N, Groopman JE, Golde DW (1982) Natural and biosynthetic insulin stimulates the growth of human erythroid progenitors in vitro. J Clin Endocrinol Metab 55: 1209-1211.
31. Perrine SP, Greene MF, Lee PD, Cohen RA, Faller DV (1986) Insulin stimulates cord blood erythroid progenitor growth: evidence for an aetiological role in neonatal polycythaemia. Br J Haematol 64: 503-511.
32. Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998) Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47: 831-835.
33. Aoki I, Taniyama M, Toyama K, Homori M, Ishikawa K (1994) Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin. Stem Cells 12: 329-338.
34. Brun JF, Aloulou I, Varlet-Marie E (2004) Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Clin Hemorheol Microcirc 30: 203-209.
35. Tateishi N, Suzuki Y, Cicha I, Maeda N (2001) O(2) release from erythrocytes flowing in a narrow O(2)-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol 281: H448-H456.
36. Tateishi N, Suzuki Y, Shirai M, Cicha I, Maeda N (2002) Reduced oxygen release from erythrocytes by the acceleration-induced flow shift, observed in an oxygen-permeable narrow tube. J Biomech 35: 1241-1251.
37. Baskurt OK, Yalcin O, Ozdem S, Armstrong JK, Meiselman HJ (2004) Modulation of endothelial nitric oxide synthase expression by red blood cell aggregation. Am J Physiol Heart Circ Physiol 286: H222-H229.
38. Bishop JJ, Nance PR, Popel AS, Intaglietta M, Johnson PC (2001) Effect of erythrocyte aggregation on velocity profiles in venules. Am J Physiol Heart Circ Physiol 280: H222-H236.
39. Wang YY, Lin SY, Liu PH, Cheung BM, Lai WA (2004) Association between hematological parameters and metabolic syndrome components in a Chinese population. J Diabetes Complications 18: 322-327.
40. Choi TS, Moon YS, Choi YH, Ko SY, Kwak KS, Kim YK (2004) The association between white blood cell counts and clustered features of the metabolic syndrome. J Korean Acad Fam Med 25: 34-39.